Blue Laser Vaporization Effective for Benign Prostatic Hyperplasia

TUESDAY, April 8, 2025 (HealthDay News) — Blue laser vaporization alleviates lower urinary tract symptoms while preserving sexual function in patients undergoing benign prostatic hyperplasia (BPH) surgery, according to a study published online March 4 in The Aging Male.

Zun-Jie Hu, from The Affiliated Taian City Central Hospital of Qingdao University in China, and colleagues assessed the impact of 450-nm blue laser vaporization on sexual function in 67 patients (median age, 65 years) undergoing BPH surgery and followed for three months.

The researchers found that blue laser vaporization significantly improved International Prostate Symptom Score, quality of life, and International Consultation on Incontinence Modular Questionnaire for Male Lower Urinary Tract Symptoms (ICIQ-MLUTS) scores. Blue laser vaporization was also significantly associated with a reduction in postvoid residual volume. There were no significant changes seen in the International Index of Erectile Function 5 score, Male Sexual Health Questionnaire for Ejaculatory Dysfunction score, or ICIQ-MLUTS sex score, demonstrating preservation of sexual function after surgery.

“To determine the longevity of these effects, additional clinical data and extended follow-up periods are necessary,” the authors write. “The findings present an effective surgical approach for safeguarding sexual function in BPH patients.”

Abstract/Full Text